Found: 8
Select item for more details and to access through your institution.
Economic impact of new active substance status on EU payers' budgets: example of dimethyl fumarate (Tecfidera®) for multiple sclerosis.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23932
- By:
- Publication type:
- Article
Is the gap between micro- and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23897
- By:
- Publication type:
- Article
Pharmaceutical expenditure forecast model to support health policy decision making.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23740
- By:
- Publication type:
- Article
Drug repurposing in pharmaceutical industry and its impact on market access: market access implications.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.22814
- By:
- Publication type:
- Article
Are payers treating orphan drugs differently?
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23513
- By:
- Publication type:
- Article
Health technology assessment in middle-income countries: recommendations for a balanced assessment system.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23181
- By:
- Publication type:
- Article
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.22813
- By:
- Publication type:
- Article
The value of quantitative patient preferences in regulatory benefit-risk assessment.
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23513
- By:
- Publication type:
- Article